Acomplia (rimonabant) and depression
admin July 20th, 2007
The European Medicines Agency (EMEA) is recommending that rimonabant (indication: obesity) should not be used in those with major depression or those taking anti-depressants because of a risk of psychiatric side effects.
Advice for patients taking rimonabant:
- If you are taking an anti-depressant, go and see your GP.
- If you start to experience symptoms of depression, go and see your GP.
- If you have had depression, continue your treatment. Next time you see your GP, discuss your treatment.
EMEA documentation relating to rimonbant.